Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Augmented Reality and 3D Model-Based Ventrogluteal Injection Training in Nursing Students (AR3D-VGI) (AR3D-VGI)

8 maggio 2026 aggiornato da: Meltem Kaya, Karabuk University

Effect of Ventrogluteal Injection Training Using Augmented Reality and a 3D Model on Nursing Students' Knowledge, Skills, Anxiety and Satisfaction

The aim of this study was to evaluate the impact of a skills training program-conducted using augmented reality (AR) and 3D model technologies-on first-year nursing students' knowledge, skills, anxiety, and satisfaction, as well as the retention of learning, regarding the correct identification of the injection site and the application of the correct technique for intramuscular (IM) injections in the deltoid (VG) region. The hypotheses of the study are as follows:

H1: There is a difference in knowledge scores regarding the administration of intramuscular injections into the ventrogluteal region between the AR group and the control group.

H2: There is a difference in skill scores regarding the administration of intramuscular injections into the ventrogluteal region between the AR and control groups.

H3: There is a difference in state anxiety scores regarding the administration of intramuscular injections into the ventrogluteal region between the AR and control groups.

H4: There is a difference in satisfaction scores regarding training methods for intramuscular injection into the ventrogluteal region between the AR and the control group.

H5: There is a difference in knowledge scores regarding intramuscular injection into the ventrogluteal region between the 3D Model group and the control group.

H6: There is a difference in skill scores regarding intramuscular injection into the ventrogluteal region between the 3D Model group and the control group.

H7: There is a difference in state anxiety scores regarding intramuscular injection into the ventrogluteal region between the 3D Model group and the control group.

H8: There is a difference in satisfaction scores regarding training methods for intramuscular injection into the ventrogluteal region between the 3D Model group and the control group.

H9: There is a difference in retention scores regarding knowledge of intramuscular injection into the ventrogluteal region between the AR and control groups.

H10: There is a difference in retention scores regarding knowledge of intramuscular injection into the ventrogluteal region between the 3D Model and control groups.

H11: There is a difference in skill retention scores regarding the application of intramuscular injection into the ventrogluteal region between the AR and the control group.

H12: There is a difference in skill retention scores regarding the application of intramuscular injection into the ventrogluteal region between the 3D Model and the control group.

After providing theoretical training to the entire group, the researcher will randomly assign participants and have them practice using the AR, a 3D hip model, and a traditional model. After four weeks, the researcher will assess retention.

Panoramica dello studio

Descrizione dettagliata

One of the most common routes nurses use to administer medications is the intramuscular injection. The literature recommends the ventrogluteal region as the safest site for intramuscular injections. However, this site is not widely used in clinical practice, leading to patients experiencing numerous complications related to intramuscular injections. For this reason, it is considered important to teach nursing students-who will become the nurses of the future-how to perform intramuscular injections into the ventrogluteal region using the correct technique. This way, nursing students will be able to administer medications safely when they begin their careers. Based on this perspective, it was believed that integrating technology into educational processes could facilitate more effective and student-centered learning. To integrate technology into educational processes, it was decided to use an AR-enabled 3D-printed hip model. Since intramuscular injection training in the ventrogluteal region is taught in the Fundamentals of Nursing course, first-year nursing students were included in the study. This research is a randomized controlled trial using AR and 3D modeling technologies.The study will be conducted with first-year nursing students during the spring semester of the 2025-2026 academic year.

Tipo di studio

Interventistico

Iscrizione (Stimato)

158

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Descrizione

Inclusion Criteria:

  • Be enrolled as a first-year student in the Department of Nursing at the Faculty of Health Sciences, Karabük University, during the spring semester of the 2025-2026 academic year.
  • Have taken the "Fundamentals of Nursing" course for the first time.
  • Have not previously received training in the skill of administering IM injections,
  • Be able to speak and understand Turkish.
  • Be willing to participate in the study.

Exclusion Criteria:

  • Failing to complete the research data collection forms in full,
  • Having previously taken the "Fundamentals of Nursing" course,
  • Withdrawing from the study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Augmented Reality Group
The AR software was developed by a computer engineer using the Unity 3D program. The researcher provided the developer with images of the ventrogluteal region and demonstrated the steps for performing an intramuscular injection into the ventrogluteal region via video. The developed AR software was ported to the Meta Quest 3 headset, which supports both virtual reality and augmented reality. With the Meta Quest 3 headset, students will be able to view virtual images in a real-world environment and perform the procedure using their hands.
Students in this group will perform intramuscular injections into the ventrogluteal region using a Meta Quest 3 headset via an augmented reality-based training application
Sperimentale: 3D Model Group
A 3D scanner and a Creality K2 Plus 3D printer located at the Iron and Steel Institute of Karabük University were used. First, the hip model located in the Anatomy Laboratory of the Faculty of Medicine at Karabük University was scanned using the 3D scanner's Blue Laser mode. Subsequently, the 3D model of the scanned hip was processed using 3D software on a computer to define dimensions, create the injection site, and determine the print slices, thereby designing the final pre-print configuration. The model was printed in four parts using the Creality K2 Plus 3D Printer and assembled to create the final model. The left side of the 3D hip model was designed to display anatomical structures for regional training, while the right side was designed to accommodate an injection port for IM injections into the VG region.
Students in this group will perform intramuscular injections into the ventrogluteal region using a 3D hip model. The model will be used as visual and tactile learning tools during the training process.
Nessun intervento: Control group
In accordance with traditional educational methods, students will perform an intramuscular injection into the ventrogluteal region using the model in the laboratory, following the step-by-step procedure.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Ventrogluteal Region Intramuscular Injection Skill Checklist Score
Lasso di tempo: Immediately after the intervention and 4 weeks after the intervention
Assessment of students' performance in administering intramuscular injections into the ventrogluteal region using a standardized skill assessment checklist.Assessment will be conducted by marking "applied" (2 points), "partially applied" (1 point), or "not applied" (0 points) for each step the student performs. The total score obtainable from the Ventrogluteal Region Intramuscular Injection Skills Checklist ranges from 0 to 64.
Immediately after the intervention and 4 weeks after the intervention

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Ventrogluteal Region Intramuscular Injection Knowledge Test Score
Lasso di tempo: Baseline (before theoretical training and randomization), immediately after the intervention, and 4 weeks after the intervention
Assessment of students' theoretical knowledge using a structured knowledge test.The knowledge test is a multiple-choice test consisting of 32 questions with five options each. Each question on the knowledge test is worth 1 point. The possible score on the test ranges from 0 to 32.Baseline measurement will be used to assess group comparability after randomization.
Baseline (before theoretical training and randomization), immediately after the intervention, and 4 weeks after the intervention
State Anxiety Scale score
Lasso di tempo: Immediately after the theoretical training session and immediately after the intervention session
Measurement of students' anxiety levels using an anxiety assessment scale.The State Anxiety Scale consists of 20 items, and the possible scores range from 20 to 80. On the State Anxiety Scale, participants rate their responses on a four-point scale ranging from "Not at all" (1) to "Completely" (4).An increase in the score obtained from the scale indicates higher levels of anxiety, whereas a decrease indicates lower levels of anxiety.
Immediately after the theoretical training session and immediately after the intervention session
Satisfaction Survey Score for Teaching Methods
Lasso di tempo: Immediately after the intervention
Evaluation of students' satisfaction with the educational method using a satisfaction questionnaire.The five-point Likert-type scale consists of 16 items. The lowest possible score on the scale is 16, while the highest is 80.An increase in the score obtained from the scale indicates higher levels of satisfaction with the educational method, whereas a decrease in the score indicates lower levels of satisfaction.
Immediately after the intervention

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Ventrogluteal Region Intramuscular Injection Knowledge Test Score
Lasso di tempo: 4 weeks after the intervention
Evaluation of the retention of knowledge 4 weeks after the intervention.The Ventrogluteal Region Intramuscular Injection Knowledge Test will be administered.The knowledge test is a multiple-choice instrument consisting of 32 items, each with five response options. Each item is scored as 1 point. The total score ranges from 0 to 32. Higher scores indicate a higher level of students' knowledge regarding ventrogluteal intramuscular injection.
4 weeks after the intervention
Ventrogluteal Region Intramuscular Injection Skill Checklist Score
Lasso di tempo: 4 weeks after the intervention
The Ventrogluteal Region Intramuscular Injection Skills Checklist will be used.The ventrogluteal intramuscular injection checklist consists of 32 steps. Each step is evaluated as follows: performed (2 points), partially performed (1 point), or not performed (0 points). The total possible score ranges from 0 to 64. A higher total score indicates a higher level of students' skill in performing ventrogluteal intramuscular injection.
4 weeks after the intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Meltem KAYA, PhD Candidate, Karabuk University
  • Cattedra di studio: Birgul CERIT, Professor, Abant Izzet Baysal University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 maggio 2026

Completamento primario (Stimato)

15 maggio 2026

Completamento dello studio (Stimato)

11 giugno 2026

Date di iscrizione allo studio

Primo inviato

4 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

8 maggio 2026

Primo Inserito (Effettivo)

13 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 2025/2658 (Altro identificatore: Karabük University Non-Interventional Clinical Research Ethics Committee)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Due to ethical considerations and institutional data protection policies, individual participant data will not be shared.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Augmented Reality Group

Sottoscrivi